• Activation factor of the systemic inflammatory response syndrome, as a predictor of the negative effects of parvovirus infection in different trimesters of pregnancy

Activation factor of the systemic inflammatory response syndrome, as a predictor of the negative effects of parvovirus infection in different trimesters of pregnancy

HEALTH OF WOMAN. 2018.3(129):95–98; doi 10.15574/HW.2018.129.95

Bondarenko N. P.
Bogomolets National Medical University, Kiev

Parvovirus infection during pregnancy can lead to abortion, intrauterine infections of the fetus with developmental defects. Subclinical forms of parvovirus infection prevail over manifestation, therefore the study of the activation factors of the systemic inflammatory response is shown as an adjunct to the diagnosis of subclinical infection among pregnant women with preterm or preterm labor with the presence of clinical complications.
Immunological studies that included the determination of the pro-inflammatory activation factor were investigated. The cytokine status and C-reactive protein as a marker of inflammation in 129 pregnant women infected with parvovirus infection in different periods of pregnancy were studied. The results were analyzed by dividing women into three groups by trimesters and by the presence of clinical complications of viral infection. Control for comparison was women with physiological pregnancy in the corresponding trimester.
An analysis of the data on the content of cytokines in serum of pregnant women revealed a change in the ratio of pro- (IL-8, IL-2 and FNP-) and anti-inflammatory (IL-10) cytokines, which may be indicative of a systemic immune response to B19 infection during various pregnancy and pregnancy.
The results of the study of C-reactive protein (hsCRP) indicate a moderate increase in its concentration in the blood of patients with parvovirus infection, which is associated with minor tissue damage. Of the 129 pregnant women with B19 infection, 57 (44.2%) women had elevated CRP levels (20% higher than the control level for the respective trimester).
Key words: parvovirus infection, pregnancy, cytokines, C-reactive protein, clinical complications of pregnancy.

REFERENCES

1. Ahushkova LM, Bulah NA, Moskalenko NP i dr. 2014. Izuchenie S-reaktivnogo proteina pri beremennosti. Fundamentalnyie issledovaniya 4–3:619–623.

2. Igipova MB, Serdyuk GV, Momot AP, Vorobeva EN. 2009. Kliniko-diagnosticheskoe znachenie S-reaktivnogo belka kak markera sistemnogo vospalitelnogo otveta pri beremennosti (obzor literaturyi). Klin. lab. diagnostika 6:3–8.

3. Kadyirova LV, Sotnikova NYu. 2014. Syivorotochnyiy uroven IL-2 i IL-15 v dinamike beremennosti. Mat i ditya v Kuzbasse. 2(57):46–48.

4. Mihaylov AV, Dyatlova LI, Zanorina TE. 2013. Osobennosti produktsii protivovospalitelnyih i provospalitelnyih tsitokinov pri beremennosti, oslozhnennoy prezhdevremennyim izlitiem okoloplodnyih vod. Sovremennyie naukoemkie tehnologii 1:115–116.

5. Aktas O, Aydin H, Uslu H. 2016. Serological prevalence of human parvovirus B19 in diseases or disorders related to different human body systems. Turkish Journal of Medical Sciences 46:368–373. https://doi.org/10.3906/sag-1409-79

6. Aysun Karabulut, Soner Gok et al. 2014, Jan. Non-immune hydrops fetalis without anemia due to parvovirus B19. International Jornal of GynecolObstet. 124:82. https://doi.org/10.1016/j.ijgo.2013.07.021; PMid:24140219

7. Chandrashekara S. 2014. C – reactive protein: An inflammatory marker with specific role in physiology, pathology, and diagnosis. Internet Journal of Rheumatology and Clinical Immunology 2(S1):SR3, 1-23. https://doi.org/10.15305/ijrci/v2iS1/117

8. Francesca Bonvicini, Gloria Bua, Giorgio Gallinella. 2017. Parvovirus B19 infection in pregnancy – awareness and opportunities. Current Opinion in Virology 27:8–14. https://doi.org/10.1016/j.coviro.2017.10.003; PMid:29096233

9. Jauniaux E, Gulbis B, Jamil A, Jurkovic D. 2015. Evaluation of the role of maternal serum high-sensitivity C-reactive protein in predicting early pregnancy failure. Reproductive BioMedicine Online 30:268–274. https://doi.org/10.1016/j.rbmo.2014.11.009; PMid:25596909

10. Joan Crane, MD, William Mundle, MD, Isabelle Boucoiran, MD. 2014. Parvovirus B19 Infection in Pregnancy. Jornal of Obstetrics and Gynaecology Canada. 36(12):1107–1116. https://doi.org/10.1016/S1701-2163(15)30390-X

11. La Marca BD, Ryan MJ, Gilbert JS et al. 2007. Serum pro in flammatory cytokines in physiological and preeclampti pregnancies. Curr. Hypertens. Rep. 9(6):480–485.

12. Nagaraj RS, Anand KP. 2017. Study of serum high sensitive C-Reactive protein and ferritin in preterm labor. International Journal of Clinical Biochemistry and Research 4(3):213-215. doi: 10.18231/2394-6377.2017.0050

13. Peltier MR, Faux DS, Hamblin SD. 2010. Cytokine production by peripheral blood mononuclear cells of women with a history of preterm birth. J. Reprod. Immunol. 84(1):111–116. https://doi.org/10.1016/j.jri.2009.10.002; PMid:20005575

14. Shahshahan Z, Rasouli O. 2014. The use of maternal C-reactive protein in the predicting of preterm labor and tocolytic therapy in preterm labor women. Adv Biomed Res. 3:154. https://doi.org/10.4103/2277-9175.137864

15. Sharmin S, Chy S, Bangladesh J. 2016. Association of Serum C-reactive Protein in Preeclampsia and its Effect on Fetal Birth Weight – A Case Control Study. ObstetGynaecol. 31(2):75–80.